European equities traded in the US as American depositary receipts were up sharply late Thursday morning, rising 1.25% to 1,372.71 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and biopharmaceutical company Genfit (GNFT), which climbed 7.3% and 4.1% respectively. They were followed by pharmaceutical company Sanofi (SNY) and electronics conglomerate Philips (PHG), which were up 3.4% and 2.6% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and accommodations booking company trivago (TRVG), which fell 27.7% and 2.5% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP (EDAP), which were down 1.5% each.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and Prudential (PUK), which rose 4.1% and 3.5% respectively. They were followed by educational publisher Pearson (PSO) and oil and gas company Shell (SHEL), which increased 3.2% and 3% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which dropped 13.3% and 5.3% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO), which lost 2.2%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。